Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype. - Orrù S; Pascariello E; Pes B; Rallo V; Barbara R; Muntoni M; Notari F; Fancello G; Mocci C; Muroni MR; Cossu-Rocca P; Angius A; et al. (Scientific reports, 2023)